-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Exelon delivered mixed Q1 results with adjusted EPS of $0.91, declining $0.01 from the prior year but exceeding consensus by $0.03, while revenue grew 7.9% to $7.2B, beating estimates by 2.9%. Operating income increased 4.5% to $1.6B, led by approved distribution and transmission rate increases across territories, though operating company results were mixed, with BGE and PECO delivering solid growth while ComEd and PHI faced headwinds. The strong revenue performance reflects successful regulatory execution with rate recovery mechanisms providing earnings visibility. Management maintained 2026 adjusted EPS guidance of $2.81-$2.91 and reiterated expectations for annualized earnings growth near the top of the 5%-7% range through 2029. The company revised its four-year capital plan to $41.7B from $41.3B, targeting 7.9% rate base growth, with financing progress on track at 43% of planned debt completed and 37% of $3.4B equity needs addressed through 2029.